<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Implantable loop recorders (ILRs) are valuable for diagnosing <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated <z:hpo ids='HP_0001649'>tachycardia</z:hpo> detection performance of the Medtronic Reveal(®) ILR with FullView™ Software.METHODS AND RESULTS: The rate of occurrence of <z:hpo ids='HP_0001649'>tachycardia</z:hpo> detection [<z:hpo ids='HP_0004755'>supraventricular tachycardia</z:hpo>, <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (VT), and <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>)] and the percentage of appropriately detected <z:hpo ids='HP_0001649'>tachycardias</z:hpo> were determined from <z:hpo ids='HP_0000001'>all</z:hpo> 2190 ILR patients that transmitted to CareLink over a 4-month period (total follow-up = 135.6 patient-years) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 1909 <z:hpo ids='HP_0001649'>tachycardia</z:hpo> episodes were reviewed </plain></SENT>
<SENT sid="3" pm="."><plain>Episodes with actual heart rate above the programmed <z:hpo ids='HP_0001649'>tachycardia</z:hpo> detection rate were classified as appropriate </plain></SENT>
<SENT sid="4" pm="."><plain>Sensitivity to detect true <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> was assessed in another group of 215 patients undergoing implantable cardioverter defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) implant testing </plain></SENT>
<SENT sid="5" pm="."><plain>Skin electrodes represented ILR electrodes </plain></SENT>
<SENT sid="6" pm="."><plain>Induced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> (404 episodes) and VT (93 episodes) were processed by an emulation of FullView Software </plain></SENT>
<SENT sid="7" pm="."><plain>Generalized estimation equation analysis adjusted for multiple episodes per patient </plain></SENT>
<SENT sid="8" pm="."><plain>In the CareLink cohort, 68.7% (63.9% adjusted) of detected episodes had <z:hpo ids='HP_0001649'>tachycardia</z:hpo> above the detection rate </plain></SENT>
<SENT sid="9" pm="."><plain>Of 1642 episodes detected in the VT zone (12.1 episodes/patient-year), 78.8% (79.0% adjusted) had <z:hpo ids='HP_0001649'>tachycardia</z:hpo> above the detection rate </plain></SENT>
<SENT sid="10" pm="."><plain>Of 267 episodes detected in the fast VT zone (1.9 episodes/patient-year), 6.7% (9.4% adjusted) had <z:hpo ids='HP_0001649'>tachycardia</z:hpo> above the detection rate </plain></SENT>
<SENT sid="11" pm="."><plain>Twelve true VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> episodes were observed in 10 patients </plain></SENT>
<SENT sid="12" pm="."><plain>In the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> patient cohort, 95.9% (96.5% adjusted) of induced VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> segments were correctly detected at nominal rate cutoffs </plain></SENT>
<SENT sid="13" pm="."><plain>When VT detection was set to 130 b.p.m </plain></SENT>
<SENT sid="14" pm="."><plain>(to include the slowest VT), 99.0% (99.3% adjusted) were correctly detected.CONCLUSION: The majority (63.9%) of detected <z:hpo ids='HP_0001649'>tachycardias</z:hpo> contained true <z:hpo ids='HP_0001649'>tachycardia</z:hpo> </plain></SENT>
<SENT sid="15" pm="."><plain>Sensitivity to detect induced VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> was 99.3% </plain></SENT>
</text></document>